Biosketch of Felix M. Arellano

Felix M Arellano is a physician with a specialty in clinical pharmacology and a co-founder of Risk Management Resources. He was trained in pharmacoepidemiology in McGill University and is a Fellow of the International Society for Pharmacoepidemiology. He received a Diploma in Pharmaceutical Medicine by the tri-state university in Basel, Switzerland. Felix has held several positions in the areas of pharmacovigilance and pharmacoepidemiology in pharmaceutical companies in Europe and the USA. Felix is a Visiting Fellow at St. Vincent's Clinical School, University of New South Wales. He is currently serving his second elected term as a member of the Board of Directors of the International Society for Pharmacoepidemiology. He has authored or co-authored numerous publications. Felix has worked with a variety of therapeutic agents in several fields, including cardiovascular, infectious diseases, ophtalmology, urology, respiratory, dermatology, arthritis & pain, neurologic disease, immunosupressive agents, cancer and transplantation (including xenotranplantation). Before founding RMR, he was the Chief Safety Officer at Pharmacia Corporation.

arellano@riskmr.com

Alejandro studied medicine at the University of Zaragoza (1990) and specialized in Preventive Medicine with a Master of Public Health of the Institute of Public Health of Valencia University (1995), and a Master of Science in Epidemiology of Erasmus University Medical School in Rotterdam (1995). Collaborated in several international projects on the epidemiology of aging and dementia at the University of Zaragoza and Erasmus University, and as advisor in Washington DC (US) for the Pan American Health Organization AIDS project in El Salvador. From 1996 worked for several pharmaceutical companies, Novartis, Pharmacia and Pfizer. Responsible for conducting several epidemiological projects, mainly in the areas of neurology and the application of epidemiological methods to the quantitative analysis of spontaneous reports. Collaborates sporadically with academia as invited lecturer in Pharmacoepidemiology & Pharmacovigilance courses (London School of Hygiene and Tropical Medicine, Université St. Antoine, Paris, Universidad de Barcelona). Is Fellow of the International Society of Pharmacoepidemiology (FISPE), member of the Board of Directors of the ISPE, and co-chair of the Industry council of ISPE.

arana@riskmr.com

Chuck is a consultant in the pharmaceutical industry specializing in the development and warehousing of large databases and performing statistical analysis. He was trained in statistics and mathematics from the University of Rhode Island and Boston University. He started his career as an analyst with Epidemiology Resources Inc. where he supported outcome and safety analysis using large health claims databases and clinical data sets. The methodological and database experience he gained at ERI propelled him to the position of Senior Director R&D of the Bioinformatics Division of Quintiles Transnational. Here, he was responsible for the development of analytic products used by the pharmaceutical industry based on the in-house proprietary pharmacy transaction database. He has worked as an independent contractor since leaving Quintiles supporting large pharmaceutical and biotech companies in database research and analytic capacities.

wentworth@riskmr.com